Wilson Lim

8PUBLICATIONS
26CO-AUTHORS
Medical mycologyAgricultural molecular engineering of nucleic acids and proteinsBiomolecular modelling and designBiologically active moleculesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 20, 2025
Structure-activity relationships of fenarimol analogues with potent in vitro and in vivo activity against Madurella mycetomatis, the main causative agent of mycetoma.

Hung Phat Duong, Dmitrij Melechov, Wilson Lim

|Jun 25, 2025
Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella.

Imad Abugessaisa, Mickey Konings, Ri-Ichiroh Manabe

|May 25, 2022
Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach.

Wilson Lim, Annelies Verbon, Wendy van de Sande

|Apr 10, 2022
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.

Bertrand Nyuykonge, Wilson Lim, Lukas van Amelsvoort

|Feb 04, 2022
Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma.

Wilson Lim, Bertrand Nyuykonge, Kimberly Eadie

|Jan 22, 2022
Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.

Wilson Lim, Mickey Konings, Florianne Parel

Pageof 2

Frequent Collaborators

6 joint publications

Wendy Wj van de Sande

3 joint publications

Matthew Todd

3 joint publications

Bertrand Nyuykonge

2 joint publications

Mickey Konings